Atrial Fibrillation Trial, Recruiting (NCT05378308)

Atrial Fibrillation Trial, Recruiting NCT05378308 Sponsor: Henan Provincial People's Hospital Condition: Atrial Fibrillation

Printed from Voxsanity (voxsanity.com.au) — NCT05378308 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Atrial Fibrillation

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been diagnosed with atrial fibrillation (an irregular heartbeat), confirmed by a heart tracing (ECG), heart monitor, or implanted device, OR you have been diagnosed with a blood clot condition (either a new or returning clot in a vein)
You have been taking blood-thinning medication (such as warfarin or a newer type of blood thinner) at some point in the last 3 months
You can take part whether you are currently in hospital or being seen as an outpatient

Who may not be able to join:

Your irregular heartbeat was caused by a temporary or treatable condition, such as a thyroid problem or occurred after surgery
You have been told your irregular heartbeat is related to a heart valve problem, specifically a damaged mitral valve (rheumatic valve disease) or an artificial/mechanical heart valve
You are already taking part in another clinical trial related to irregular heartbeat or blood clots
You need blood-thinning medication for reasons other than an irregular heartbeat or blood clot condition (confirm with trial site)
Your medical records are incomplete, contain unclear information, or do not have enough detail for the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Shujuan Zhao, Henan Provincial People's Hospital

Phone: 0086-13837101436

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05378308

Sponsor: Henan Provincial People's Hospital

Phase: Not Applicable

Status: Recruiting

Condition: Atrial Fibrillation

Trial contact: 0086-13837101436

More information: https://clinicaltrials.gov/study/NCT05378308

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been diagnosed with atrial fibrillation (an irregular heartbeat), confirmed by a heart tracing (ECG), heart monitor, or implanted device, OR you have been diagnosed with a blood clot condition (either a new or returning clot in a vein)
You have been taking blood-thinning medication (such as warfarin or a newer type of blood thinner) at some point in the last 3 months
You can take part whether you are currently in hospital or being seen as an outpatient

Who may not be able to join:

Your irregular heartbeat was caused by a temporary or treatable condition, such as a thyroid problem or occurred after surgery
You have been told your irregular heartbeat is related to a heart valve problem, specifically a damaged mitral valve (rheumatic valve disease) or an artificial/mechanical heart valve
You are already taking part in another clinical trial related to irregular heartbeat or blood clots
You need blood-thinning medication for reasons other than an irregular heartbeat or blood clot condition (confirm with trial site)
Your medical records are incomplete, contain unclear information, or do not have enough detail for the study

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Henan Provincial People's Hospital

Registry

ClinicalTrials.gov

Start date

6 June 2022

Est. completion

31 May 2027

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Profiles of patients with OACs; Patients with AF prescribed with OAC; Patients with VTE prescribed with OAC

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov